| Literature DB >> 33651145 |
Alexander Maslaris1,2,3, Thomas P Vail4, Alan L Zhang4, Rina Patel5, Stefano A Bini6.
Abstract
BACKGROUND: Gluteal tendon tears (GTT) can cause pain and weakness of the hip. We analyze the impact of gluteal muscle fatty degeneration, atrophy and tear morphology on clinical outcomes of surgical repair.Entities:
Keywords: Fatty degeneration of gluteal muscles; Gluteal tendon refixation techniques; Gluteal tendon repair; Gluteal tendon rupture; Gluteus medius et minimus tear
Mesh:
Year: 2021 PMID: 33651145 PMCID: PMC9381454 DOI: 10.1007/s00402-021-03787-2
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 2.928
Fig. 1An axial T1 sequence of an MRI illustrating the Gmin and the three district parts of Gmed, that were included in the assessment of fatty degeneration as described by Thaunat [6]: Gmin (rot), anterior portion (blue), mid portion (yellow) and posterior portion of Gmed (green)
Fig. 2a–d Preoperative MRI revealing a GTT on the left side. In the axial views a the right healthy side and b the anteroposterior detachment on the lateral aspect of trochanter. In the coronal plane c and d the retraction of the torn gluteal muscle compared to the healthy contralateral hip
Fig. 3Percentage of the overall cases with verified improvement of the main outcome objectives after surgical treatment of GTT
Demographics, findings and outcomes in relation to fatty degeneration of gluteal muscle according to Goutallier-Fuchs Classification (values in means + standard deviation)
| GFC | 0° | 1° | 2° | 3° | All |
|---|---|---|---|---|---|
| Nr | 6 (15.8%) | 16 (42.1%) | 10 (26.3%) | 6 (15.8%) | 38 |
| Age | 64 ± 12.2 | 63 ± 8.6 | 69,5 ± 11.3 | 71,5 ± 4.6 | 66.7 ± 9.9 |
| Gender (females) | 5 (83.3%) | 13 (81.3%) | 6 (60%) females | 5 (83.3%) | 29 (78%) |
| ASA | 1 (16.7%) I° 3 (50%) II° 2 (33.3%) III° | 0 (0%) I° 14 (87.5%) II° 2 (12.5%) III° | 1 (10%) I° 7 (70%) II° 2 (20%) III° | 1(16.7%) I° 4 (66.7%) II° 1 (16.7%) III° | 3 (7.9%) I° 28 (73.7%) II° 7 (18.4%) III° |
| BMI | 28.24 ± 6.5 | 27,7 ± 4.2 | 30,2 ± 7.6 | 27 ± 5.7 | 28,33 |
| Etiology | 5 (83.3%) spontaneous 1 (17%) posttraumatic | 13 (81.3%) spontaneous 2 (12,5%) posttraumatic 1 (6.3%) prior THA | 2 (20%) spontaneous 1 (10%) posttraumatic 7 (70%) prior THA | 2 (33.3%) spontaneous 1 (16.7%) posttraumatic 3 (50%) prior THA | 22 (57.9%) spontaneous 5 (13.2%) posttraumatic 11 (28.9%) prior THA |
| THA approaches | None | 1/1 LA | 4/4 LA | 2/3 LA | 7/8 (87.5%) LA |
| Prior RHA nr | None | None | 2 (20%) ≥ 3 RHA 1 (10%) < 3 RHA | none | 3 prior RHA (1: < 3, 2: ≥ 3 RHAs) |
| FOS (mm) | 46.5 ± 1.5 | 46.8 ± 6.9 | 48.2 ± 4.7 | 46.6 ± 6.7 | 47.1 ± 5.6 |
| Injured tendons | 60% Gmed 20% Gmin 20% Gmed & Gmin | 50% Gmed 12.5% Gmin 31.3% Gmed & Gmin | 50% Gmed 0% Gmin 50% Gmed & Gmin | 16.7% Gmed 83.3% Gmed & Gmin | 17 45.6% Gmed 3 8.1% Gmin 16 43.2% Gmed & Gmin |
| Tear type Gmed | 40% PT 40% FT | 31.3% PT 43.8% FT | 40% PT 60% FT | 16.7% PT 83.3% FT | 31.6% PT 52.6% FT |
| Tear type Gmin | 0% FT 40% PT | 31.3% PT 18.8% FT | 30% PT 20% FT | 33.3% PT 50% FT | 26.3% PT 21% FT |
Retraction Gmed in mm | 0 | 5.6 ± 10.7 | 18.7 ± 18.3 | 20.5 ± 23.9 | 8.8 ± 1.5 |
| Tear size in mm | 11.3 ± 2.3 | 13.8 ± 8.9 | 19 ± 11.1 | 30.2 ± 9.9 | 15.5 ± 10.8 |
| Muscle atrophy (< 25%) | 50% | 54% | 94% | 100% | 75% |
| Bursitis | 1.2 ± 0.8 | 1.1 ± 0.8 | 1.9 ± 1.1 | 2.3 ± 1.2 | 1.54 ± 1.0 |
| Treatment | 5 (83.3%) OGR 1 (16.7%) EGR | 9 (56.3%) OGR: 7 (43.8%) EGR | 9 (90%) OGR: 1 (10%) EGR | 6 (100%) OGR: | 29 (76.3%) OGR: 9 (23.7%) EGR |
| Technique | 10/6 anchors (mean 1.7 + 0.5) | 31/16 anchors (mean 1.9 ± 0.9) | 29/10 anchors (mean 2.9 ± 1.1) 1/10 mesh 1/10 GmaxT | 16/6 anchors (mean 2.7 ± 1.2) | 86/38 anchors (mean 2.3 ± 1.0) 1/38 mesh |
| Follow-up (months) | 24.7 ± 10.5 | 22.4 ± 16 | 19.7 ± 5.5 | 15.3 ± 10.5 | 20.92 ± 12.51 |
Abduction av. Improvement | + 0.5 ± 0.6/5 | + 0.46 ± 0.9/5 | + 0.4 ± 0.5/5 | + 0.5 ± 0.5/5 | + 0.46 ± 0.7/5** |
Limp av. improvement | − 1.2 ± 0.8/3 | − 1.1 ± 1.1/3 | 0 ± 1.2/3 | − 0.5 ± 1.8/3 | − 0.68 ± 1.3/3** |
Non-opioid analgesics %-reduction | − 7/8 (87.5%) | − 20/25 (80%) | − 16/20 (80%) | − 7/7 (100%) | − 50/60 (83.3%)** |
Opioid ‘%-reduction | − 2/2 (100%) | − 6/8 (75%) | − 3/4 (75%) | 0.0 | − 11/14 (78.6%)** |
VAS av. improvement | − 3.6/10 | − 4.9/10 | − 3.7/10 | − 3.5/10 | − 4.14/10 ** |
| 67 ± 17.4/100 | 78.7 ± 14.3/100 | 67 ± 29.5/100 | 74.6 ± 18.4/100 | 72.99 ± 20.6/100 | |
| 65.2 ± 11.3/91 | 74 ± 14.4/91 | 58 ± 21.3/91 | 58.5 ± 24.3/91 | 65.51 ± 18.9/91 | |
| Complications | None | None | 4 × after rOGR | 2 × after rOGR | 6/38 (16%) all after rOGR |
GFC Goutallier-Fuchs Classification, ASA American Society of Anesthesiologist, BMI Body-Mass-Index, THA total hip arthroplasty, LA lateral approach, RHA revision hip arthroplasty, OGR open gluteal repair, pOGR primary open gluteal repair, rOGR revision hip arthroplasty with open gluteal repair, EGR endoscopic gluteal repair, GmaxT gluteus maximus transfer, Gmed gluteus medius, Gmin gluteus minimus, PT partial tear, FT full-thickness tear, VAS Visual Analog Scale of pain, HOOS Hip disability and Osteoarthritis Outcome Score Junior, HHS Harris Hip Score
*Significance at the 0.05 level (2-tailed)
**Significance at the 0.01 level (2-tailed)
Fig. 4Means of postoperative improvement of the tested outcome variables between GFC < 2° and GFC ≥ 2°
Mean differences of pain, limp, abduction strength, Nr. of analgesics and opioids before and after surgery for the groups GFC < 2° and GFC ≥ 2°
| VAS | Limp | Abduction | Analgesics | Opioid | |
|---|---|---|---|---|---|
| GFC < 2° | − | − | − | − | |
| GFC ≥ 2° | − | − 0.2 | − | − 75% | |
| All patients | − | − | − | ||
| One-way ANOVA of mean differences comparing outcomes of independent groups | |||||
| GFC < 2° vs. ≥ 2° | 0.95 | 0.03 | 5% | 5% | |
*Significance at the 0.05 level (2-tailed)
**Significance at the 0.01 level (2-tailed)
Demographics, findings and outcomes in relation to fatty degeneration of the muscle of gluteus medius et minimus according to Goutallier-Fuchs Classification divided in < 2° and ≥ 2° with reports of its significant differences (P values)
| GFC | < 2° | ≥ 2° | < 2° vs. ≥ 2° |
|---|---|---|---|
| Nr | 22 (57.9%) | 16 (42.1%) | 0.33 |
| Age | 63 ± 9.4 | 70 ± 9.2 | |
| Gender (females) | 18 (81.8%) | 11 (68.8%) | 0.38 |
| BMI | 27.81 ± 4.7 | 29 ± 6.9 | 0.56 |
| Etiology | 18 (81.8%) spontaneous 3 (13.6%) posttraumatic 1 (4.5%) prior THA | 4 (25%) spontaneous 2 (12.5%) posttraumatic 10 (62.5%) prior THA | |
| Lateral THA approaches | 1/1 (100%) LA | 6/7 (85.7%) LA | |
| Prior RHA (nr.) | None | 2/10 (20%) ≥ 3 RHA 1/10 (10%) < 3 RHA | |
| Injured tendons | 52.4% Gmed 14.3% Gmin 28.6% Gmed & Gmin | 37.5% Gmed 0% Gmin 62.5% Gmed & Gmin | 0.08 |
| Tear type Gmed | 38% PT 42.9% FT 19% isolated Gmin PT | 31.3% PT 68.8% FT | |
| Tear size in mm | 13.4 ± 8.1 | 23.3 ± 11.7 | |
| Retraction Gmed in mm | 3.2 ± 8.4 | 19.4 ± 19.3 | |
| Muscle atrophy (≥ 25%) | 53% | 96.4% | |
| Bursitis | 1.14 ± 0.8 | 2.1 ± 1.1 | |
| Treatment | 14 (63.6%) OGR: 8 (36.4%) EGR | 15 (93.8%) OGR: 1 (6.3%) EGR | |
| Nr. of anchors | 41/22 (mean 1.86 ± 0.8) | 45/16 (mean 2.81 ± 1.1) | |
| Abduction av. Improvement | + 0.47 ± 0.8/5 | + 0.5 ± 0.5/5 | 0.91 |
| Limp av. improvement | − 1.2 ± 1/3 | − 0.2 ± 1.4/3 | |
| Analgesics av. reduction | − 27/33 (-81.8%) | − 23.5/27 (− 87%) | 0.31 |
| Opioid av. reduction | − 8/10 (− 80%) | − 3/4 (− 75%) | 0.35 |
| VAS av. improvement | − 4.6 ± 2.6/10 | − 3.6 ± 2.9/10 | 0.32 |
| 75.6 ± 15.6/100 | 69.7 ± 25.4/100 | 0.44 | |
| 71.7 ± 13.9/91 | 58.2 ± 21.7/91 | ||
| Complications | None (0%) | 6 after ROR (37.5%) |
Significant values are highlighted in bold
GFC Goutallier-Fuchs Classification, BMI Body-Mass-Index, THA total hip arthroplasty, LA lateral approach, RHA revision hip arthroplasty, Gmed gluteus medius, Gmin gluteus minimus, PT partial tear, FT full-thickness tear, OGR open gluteal repair, pOGR primary open gluteal repair, rOGR revision open gluteal repair (revision total hip arthroplasty with open repair), EGR endoscopic gluteal repair
Demographics, findings and outcomes in relation to atrophy of the abductor muscle with reports of significant differences (P values)
| Atrophy of abductor muscles (≥ 25%) | No | Yes | < 25% vs. ≥ 25% |
|---|---|---|---|
| Cases (%) | 36% | 64% | |
| Age | 61.9 ± 9.2 | 68 ± 9.6 | 0.12 |
| Gender (females) | 7 (70%) | 15 (83.3%) | 0.46 |
| BMI | 28.29 ± 4.7 | 28.28 ± 6.8 | 1.00 |
| ASA | 0 (0%) I° 10 (100%) II° 0 (0%) III° | 2 (11.1%) I° 11 (61.1%) II° 5 (27.8%) III° | 0.27 |
| Etiology | 8 (80%) spontaneous 1 (10%) posttraumatic 1 (10%) prior THA | 7 (38.9%) spontaneous 2 (11.1%) posttraumatic 9 (50%) prior THA | |
| Lateral THA approaches | 1/1 LA | 6/9 LA | 0.14 |
| Prior RHA (nr.) | None | 2/9 (22.2%) ≥ 3 RHA 1/9 (11.1%) < 3 RHA | 0.10 |
| Injured tendons | 50% Gmed 20% Gmin 30% Gmed & Gmin | 50% Gmed 0% Gmin 50% Gmed & Gmin | 0.60 |
| Tear type Gmed | 50% PT 30% FT | 33.3% PT 66.7% FT | |
| Tear size in mm | 13.7 ± 8.2 | 20 ± 1.3 | 0.17 |
| Retraction Gmed in mm | 0 ± 0 | 15.3 ± 1.9 | |
| GFC | 1.48 ± 0.9 | 2.6 ± 0.8 | |
| Bursitis | 0.8 ± 0.6 | 2.0 ± 1.1 | |
| Treatment | 4 (40%) OGR: 6 (60%) EGR | 16 (88.9%) OGR: 2 (11.1%) EGR | |
| Nr. of anchors | 22/10 (mean 2.2 ± 0.9) | 45/18 (mean 2.5 ± 1.2) | 0.46 |
Abduction av. improvement | + 0.22 ± 0.4/5 | + 0.61 ± 0.5/5 | 0.09 |
Limp av. improvement | − 0.9 ± 1.2/3 | − 0.4 ± 1.5/3 | 0.38 |
Analgesics av. reduction | − 12/14 (− 85.7%) | − 28/31 (-90.3%) | 0.19 |
Opioid av. reduction | − 4/5 (− 80%) | − 4/5 (− 80%) | 0.40 |
VAS av. improvement | − 3.9 ± 2.0/10 | − 3.8 ± 2.6/10 | 0.97 |
| 72.1 ± 17.36/100 | 75.6 ± 15.6/100 | 0.71 | |
| 72.88 ± 14.3/91 | 63.17 ± 21.12/91 | 0.19 | |
| Complications | 1 (10%) after rOGR | 4 (22%) all after rOGR | 0.89 |
Significant values are highlighted in bold